Aetiology, practice patterns and burden of end-stage kidney disease in South Asia and South-East Asia: A questionnaire-based survey.

Autor: Sahay M; Department of Nephrology, Osmania General Hospital, Hyderabad, India., Jasuja S; Department of Nephrology, Indraprastha Apollo Hospital, Delhi, India., Tang SCW; Department of Nephrology, Queen Mary Hospital, Hong Kong Society of Nephrology, Pok Fu Lam, Hong Kong., Alexander S; Department of Nephrology, Christian Medical College Vellore, Tamil Nadu, 632004, India., Jha V; Department of Nephrology, George Institute of Global Health, Delhi, India., Vachharajani T; Department of Nephrology, Cleveland Clinic, Cleveland, Ohio, USA., Mostafi M; Department of Nephrology, Armed Forces Medical College, Dhaka, Bangladesh., Pisharam JK; Department of Nephrology, Ministry of Health, Brunei, Darussalam Medical Services, Bandar Seri Begawan, Brunei Darussalam., Jacob C; Department of Nephrology, Bengaluru, Bangalore Baptist Hospital, India., Gunawan A; Department of Nephrology, Brawijaya University, Malang, Indonesia., Bak Leong G; Department of Nephrology, Serdang Hospital, Serdang, Malaysia., Thwin KT; Department of Nephrology, University of Medicine, Yangon, Myanmar., Agrawal RK; Department of Nephrology, Bir Hospital, Kathmandu, Nepal., Vareesangthip K; Department of Nephrology, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Tanchanco R; Department of Nephrology, The Medical City, Metro Manila, Philippines., Choong L; Department of Nephrology, Singapore General Hospital, Singapore, Singapore., Herath C; Department of Nephrology, Sri Jayewardenepura General Hospital, Sri Jayawardenepura Kotte, Sri Lanka., Lin CC; Department of Nephrology, Taipei Veterans General Hospital, Taipei, Taiwan., Cuong NT; Department of Nephrology, Hochiminh City National University, Hochiminh, Vietnam., Haian HP; Department of Nephrology, Viet Duc University Hospital, Hanoi, Vietnam., Akhtar SF; Department of Nephrology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan., Alsahow A; Department of Nephrology, Jahara Hospital, Al Jahra, Kuwait., Rana DS; Department of Nephrology, Sir Gangaram Hospital, Delhi, India., Rajapurkar MM; Department of Nephrology, Muljibhai Patel Urological Hospital, Gujrat, India., Kher V; Department of Nephrology, Medanta Hospital Gurugram, Gurugram, India., Verma S; Clinical Research, AVATAR foundation, New Delhi, India., Ramachandran R; Department of Nephrology, PGIMER, Chandigarh, India., Bhargava V; Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India., Puri S; Department of Nephrology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersy, USA., Sagar G; Department of Nephrology, Indraprastha Apollo Hospital, Delhi, India., Bahl A; Department of Nephrology, Indraprastha Apollo Hospital, Delhi, India., Mandal S; Department of Nephrology, Columbia Asia Hospital, Gurugram, India., Gupta A; Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India., Gallieni M; Department of Nephrology, 'L. Sacco' Department of Biomedical and Clinical Sciences, University of Milano, Milan, Italy.
Jazyk: angličtina
Zdroj: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2021 Feb; Vol. 26 (2), pp. 142-152. Date of Electronic Publication: 2020 Dec 28.
DOI: 10.1111/nep.13825
Abstrakt: Aim: There is paucity of data on the epidemiology of end-stage kidney disease (ESKD) from South Asia and South-East Asia. The objective of this study was to assess the aetiology, practice patterns and disease burden and growth of ESKD in the region comparing the economies.
Methods: The national nephrology societies of the region; responded to the questionnaire; based on latest registries, acceptable community-based studies and society perceptions. The countries in the region were classified into Group 1 (High|higher-middle-income) and Group 2 (lower|lowermiddle income). Student t-test, Mann-Whitney U test and Fisher's exact test were used for comparison.
Results: Fifteen countries provided the data. The average incidence of ESKD was estimated at 226.7 per million population (pmp), (Group 1 vs. Group 2, 305.8 vs. 167.8 pmp) and average prevalence at 940.8 pmp (Group 1 vs. Group 2, 1306 vs. 321 pmp). Group 1 countries had a higher incidence and prevalence of ESKD. Diabetes, hypertension and chronic glomerulonephritis were most common causes. The mean age in Group 2 was lower by a decade (Group 1 vs. Group 2-59.45 vs 47.7 years).
Conclusion: Haemodialysis was the most common kidney replacement therapy in both groups and conservative management of ESKD was the second commonest available treatment option within Group 2. The disease burden was expected to grow >20% in 50% of Group 1 countries and 78% of Group 2 countries along with the parallel growth in haemodialysis and peritoneal dialysis.
(© 2020 Asian Pacific Society of Nephrology.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje